Home » Topics » BioWorld Science

BioWorld Science
RSS

Kanebo reports antitumor agent with a novel mechanism of action

Oct. 11, 1996

Japanese researchers report new antimetastatic agents

Oct. 11, 1996

MMP inhibitors from Otsuka

Oct. 11, 1996

DuPont Merck describes bisnaphthalimide anticancer drugs

Oct. 11, 1996

ProScript licenses rights to inhibitors of Ras processing

Oct. 11, 1996

Merck describes natural inhibitors of Ras farnesylation

Oct. 11, 1996

Farnesyltransferase inhibitors discovered by RPR

Oct. 11, 1996

Ovarian cancer vaccine enters phase II/III trials

Oct. 11, 1996

New company focuses on small molecules that mimic binding regions of Ig proteins

Oct. 11, 1996

Patent coverage for The Immune Response Corporation's colon cancer vaccine

Oct. 11, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...